MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease
Left ventricular hypertrophy (LVH) is a primary feature of cardiovascular complications in patients with chronic kidney disease (CKD). miRNA-30 is an important posttranscriptional regulator of LVH, but it is unknown whether miRNA-30 participates in the process of CKD-induced LVH. In the present stud...
Main Authors: | Jingfu Bao, Yinghui Lu, Qinying She, Weijuan Dou, Rong Tang, Xiaodong Xu, Mingchao Zhang, Ling Zhu, Qing Zhou, Hui Li, Guohua Zhou, Zhongzhou Yang, Shaolin Shi, Zhihong Liu, Chunxia Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2021-05-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.138027 |
Similar Items
-
A systems biology approach identifies the role of dysregulated PRDM6 in the development of hypertension
by: Kushan L. Gunawardhana, et al.
Published: (2023-03-01) -
Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Case-Based Narrative Review
by: Aamir Javaid, et al.
Published: (2025-06-01) -
Heart Rate Variability and Electrocardiographic Parameters Predictive of Arrhythmias in Dogs with Stage IV Chronic Kidney Disease Undergoing Intermittent Haemodialysis
by: Angélica Alfonso, et al.
Published: (2020-10-01) -
Inhibition of the renin-angiotensin system causes concentric hypertrophy of renal arterioles in mice and humans
by: Hirofumi Watanabe, et al.
Published: (2021-12-01) -
The Value of Clinical Decision Support in Healthcare: A Focus on Screening and Early Detection
by: Hendrik Schäfer, et al.
Published: (2025-03-01)